Scott Sensenbrenner, Chief Executive Officer
Sensenbrenner plans and directs all aspects of Enzymedica’s policies, objectives and initiatives, and is responsible for both the short and long-term profitability and growth of the company. Sensenbrenner has an extensive track record with some of the industry’s leading nutritional companies, including Enzymatic Therapy and Perrigo (PRGO – NASDAQ), the largest generic pharmaceutical, OTC and nutritional company in the United States. Prior to joining Enzymedica, Sensenbrenner served as Vice President of Marketing and Sales for Thorne Research, a leading manufacturer and marketer of therapeutic supplements sold exclusively to health care practitioners.
Luis Labrador, Vice President of International Sales
Labrador oversees Enzymedica’s international account base. His primary goal is the strategic global expansion of Enzymedica. He has successfully established the brand into Canada, Dubai, New Zealand and Germany. Labrador holds a master’s degree in education and language, is fluent in English and Spanish, and studied French. He has an extensive sales background and brings skills learned as a real estate project manager, overseeing large-scale projects in a variety of geographic areas to the international department.
Shane McCombs, Chief Information Officer
McCombs directs and manages strategic IT plans, policies, programs and schedules for business and finance data processing. Additionally, he educates employees about Lean Six Sigma methodology to encourage Enzymedica’s continuous improvement. McCombs oversees the company’s computer services, network communications, and management information services to accomplish Enzymedica’s corporate goals and objectives.